Departamento de Endocrinología, Fundación Valle del Lili, Cali, Colombia.
Centro de Investigaciones Clínicas, Fundación Valle del Lili, Cali, Colombia.
BMC Health Serv Res. 2023 Mar 30;23(1):314. doi: 10.1186/s12913-023-09267-0.
Noncommunicable diseases such as diabetes mellitus (DM) have gained attention worldwide. Latin America experienced a rise in rates of DM. During the COVID-19 pandemic, a telemedicine program was implemented in a quaternary care academic complex in Latin America to continue the follow-up of patients with diabetes.
The aim of this study is to describe the clinical experience of DM patient management through telemedicine and the HbA1c behavior of patients followed-up through this modality.
We conducted a retrospective cohort study including all patients with type 1 or 2 diabetes who were treated via telemedicine from March to December 2020. A Wilcoxon statistical test was used to compare the changes in glycosylated hemoglobin between the first teleconsultation and after 6 months of telemedicine follow-up.
A total of 663 patients were included, 17.65% (117) of whom had type 1 diabetes and 82.35% (546) of whom had type 2 diabetes. Patients with both types of diabetes, presented with stable HbA1c values regardless of the length of follow-up.
The use of telemedicine can be a helpful tool for both patients and health care providers to support the continuity of care to maintain acceptable control levels within glycemic control goals.
糖尿病等非传染性疾病在全球范围内受到关注。拉丁美洲的糖尿病发病率上升。在 COVID-19 大流行期间，拉丁美洲的一家四级保健学术中心实施了远程医疗计划，以继续对糖尿病患者进行随访。
本研究旨在描述通过远程医疗管理糖尿病患者的临床经验，以及通过这种方式随访的患者的糖化血红蛋白（HbA1c）行为。
我们进行了一项回顾性队列研究，纳入了所有在 2020 年 3 月至 12 月期间通过远程医疗治疗的 1 型或 2 型糖尿病患者。采用 Wilcoxon 统计检验比较首次远程咨询和远程医疗随访 6 个月后糖化血红蛋白的变化。
共纳入 663 例患者，其中 17.65%（117 例）为 1 型糖尿病，82.35%（546 例）为 2 型糖尿病。无论随访时间长短，两种类型的糖尿病患者的 HbA1c 值均保持稳定。
远程医疗的使用可以成为患者和医疗保健提供者的有用工具，有助于维持医疗服务的连续性，以保持血糖控制目标内可接受的控制水平。
